CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment

BACKGROUND: Bone is the predominant site of metastasis from breast cancer, and recent trials have demonstrated that adjuvant bisphosphonate therapy can reduce bone metastasis development and improve survival. There is an unmet need for prognostic and predictive biomarkers so that therapy can be appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Westbrook, Jules A., Cairns, David A., Peng, Jianhe, Speirs, Valerie, Hanby, Andrew M., Holen, Ingunn, Wood, Steven L., Ottewell, Penelope D., Marshall, Helen, Banks, Rosamonde E., Selby, Peter J., Coleman, Robert E., Brown, Janet E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808632/
https://www.ncbi.nlm.nih.gov/pubmed/26757732
http://dx.doi.org/10.1093/jnci/djv360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808632/
https://www.ncbi.nlm.nih.gov/pubmed/26757732
http://dx.doi.org/10.1093/jnci/djv360

Ejemplares similares